
- Volume 0 0
US Rx Drug Sales to Skyrocket During 2006
The new Medicare Part D prescriptiondrug program is expected to triggera sharp increase in the demand forRx medicines during the coming year,researchers at IMS Health predict. USsales of prescription drugs are projectedto grow by between 8% and 9% in2006—an increase almost 50% greaterthan the worldwide rise in demandfor medicines and double the salesgrowth expected for many Europeancountries.
Currently, US sales of prescriptiondrugs total $230 billion, or 43% of theworldwide market for these products.The upsurge in demand next year figuresto push the US share of the globalpharmaceutical market even higher,according to IMS Health.
Mr. Rankin is a freelance medical writer.
Articles in this issue
almost 20 years ago
CAN YOU READ THESE Rxs?almost 20 years ago
Bar Coding Thwarts Illegitimate Drug Usealmost 20 years ago
COMPREHENSIVE CARE CLINIC: DIABETES: Diabetes-related Stress and Depressionalmost 20 years ago
Hypertension Counseling Requires a Multifactorial Approachalmost 20 years ago
COMPOUNDING HOTLINEalmost 20 years ago
Pharmacy Law: Duty to Warn Waived When Patient Refuses Counselingalmost 20 years ago
EnterpriseRx Pharmacy Management Systemalmost 20 years ago
Hospital Installs Automated Medication Cabinetsalmost 20 years ago
"Smartphones" Help with Clinical Trial Informationalmost 20 years ago
HIT Needs Medicare's LeadershipNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































